Trials / Completed
CompletedNCT01205048
Emervel Classic Lidocaine Versus Juvederm® Ultra in Treatment of Moderate to Severe Facial Wrinkles and Folds
A Pivotal USA Randomized, Evaluator-blinded, Active-controlled, Multi-center, Split-face Comparison Study of Emervel Classic Lidocaine Versus Juvederm® Ultra in the Treatment of Moderate to Severe Facial Wrinkle Folds
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 171 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effectiveness and safety of Emervel Classic Lidocaine versus Juvederm® Ultra in the treatment of moderate to severe facial wrinkles and folds.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Emervel Classic Lidocaine | 20 mg/mL + 0.3% lidocaine |
| DEVICE | Juvederm® Ultra | 24mg/mL |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2011-06-27
- Completion
- 2012-01-19
- First posted
- 2010-09-20
- Last updated
- 2023-07-25
- Results posted
- 2023-07-25
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01205048. Inclusion in this directory is not an endorsement.